News New Roche flu treatment moves one step closer Swiss pharma giant Roche today announced positive results from its second round phase III (PIII) pivotal data.
News Roche to file Tecentriq in triple negative breast cancer No other immunotherapies are approved in indication
News Roche drug too pricey in progressive MS, says NICE Ocrevus is effective but too pricey in PPMS, says NICE
Market Access NICE okays Roche rare lung cancer drug after price cut Alecensa has aced Pfizer's rival in head-to-head trial
News NICE okays NHS funding for MS and eczema drugs The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.
News Tesaro stock rockets as rumours of Roche takeover abound Shares in US biotech Tesaro peaked this week amid speculation that Roche is making plans to buy it.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.